Get started
ALLIANCE PHARMA PLC ORD GBP0.01ALLIANCE PHARMA PLC ORD GBP0.01ALLIANCE PHARMA PLC ORD GBP0.01

ALLIANCE PHARMA PLC ORD GBP0.01

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

APH chart


Full chart

APH upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪239.47 M‬ GBP
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.05 GBP
Net income (FY)
‪−33.14 M‬ GBP
Revenue (FY)
‪180.68 M‬ GBP
Shares float
‪389.70 M‬
Beta (1Y)
1.13

Employees


Employees (FY)
292
Change (1Y)
+7 +2.46%
Revenue / Employee (1Y)
‪787.69 K‬ GBP
Net income / Employee (1Y)
‪−144.46 K‬ GBP

About ALLIANCE PHARMA PLC


Sector
Health Technology
CEO
Nick Sedgwick
Headquarters
Chippenham
Website
alliancepharma.co.uk
Founded
2001
ISIN
GB0031030819
FIGI
BBG000BB8ZP9
Alliance Pharma Plc is a holding company, which engages in the provision of acquisition, marketing, and distribution of healthcare and pharmaceutical products. It holds marketing rights to a range of healthcare brands and prescription medicines. The company was founded by John Dawson in 1996 and is headquartered in Chippenham, the United Kingdom.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

APH news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of APH is 44.80 GBX — it has increased by 0.49% in the past 24 hours. Watch ALLIANCE PHARMA PLC ORD GBP0.01 stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange ALLIANCE PHARMA PLC ORD GBP0.01 stocks are traded under the ticker APH.
APH stock has fallen by −2.59% compared to the previous week, the month change is a −0.97% fall, over the last year ALLIANCE PHARMA PLC ORD GBP0.01 has showed a 20.85% increase.
We've gathered analysts' opinions on ALLIANCE PHARMA PLC ORD GBP0.01 future price: according to them, APH price has a max estimate of 85.00 GBX and a min estimate of 42.00 GBX. Watch APH chart and read a more detailed ALLIANCE PHARMA PLC ORD GBP0.01 stock forecast: see what analysts think of ALLIANCE PHARMA PLC ORD GBP0.01 and suggest that you do with its stocks.
APH reached its all-time high on Sep 7, 2021 with the price of 123.00 GBX, and its all-time low was 2.00 GBX and was reached on Jan 6, 2009. View more price dynamics on APH chart.
See other stocks reaching their highest and lowest prices.
APH stock is 1.92% volatile and has beta coefficient of 1.13. Track ALLIANCE PHARMA PLC ORD GBP0.01 stock price on the chart and check out the list of the most volatile stocks — is ALLIANCE PHARMA PLC ORD GBP0.01 there?
Today ALLIANCE PHARMA PLC ORD GBP0.01 has the market capitalization of ‪243.25 M‬, it has decreased by −2.31% over the last week.
Yes, you can track ALLIANCE PHARMA PLC ORD GBP0.01 financials in yearly and quarterly reports right on TradingView.
ALLIANCE PHARMA PLC ORD GBP0.01 is going to release the next earnings report on Mar 25, 2025. Keep track of upcoming events with our Earnings Calendar.
ALLIANCE PHARMA PLC ORD GBP0.01 revenue for the last half-year amounts to ‪84.80 M‬ GBX, despite the estimated figure of ‪84.80 M‬ GBX. In the next half-year revenue is expected to reach ‪102.90 M‬ GBX.
APH net income for the last half-year is ‪4.66 M‬ GBP, while the previous report showed ‪−38.24 M‬ GBP of net income which accounts for 112.19% change. Track more ALLIANCE PHARMA PLC ORD GBP0.01 financial stats to get the full picture.
As of Nov 21, 2024, the company has 292.00 employees. See our rating of the largest employees — is ALLIANCE PHARMA PLC ORD GBP0.01 on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ALLIANCE PHARMA PLC ORD GBP0.01 EBITDA is ‪51.21 M‬ GBP, and current EBITDA margin is 24.90%. See more stats in ALLIANCE PHARMA PLC ORD GBP0.01 financial statements.
Like other stocks, APH shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ALLIANCE PHARMA PLC ORD GBP0.01 stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ALLIANCE PHARMA PLC ORD GBP0.01 technincal analysis shows the neutral today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ALLIANCE PHARMA PLC ORD GBP0.01 stock shows the neutral signal. See more of ALLIANCE PHARMA PLC ORD GBP0.01 technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.